The FDA has given premarket approval to Seno Medical for its Imagio Breast Imaging System that helps differentiate between malignant and benign breast lesions.
FDA OKs breast cancer diagnostic from Seno Medical
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.